Chlorella vulgaris Modulates Gut Microbiota and Induces Regulatory T Cells to Alleviate Colitis in Mice
Nutrients · 25.07.2023 · 15 (15) · 3293
DOI: 10.3390/nu15153293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 25.07.2023. Verfasst von Priyanka Velankanni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Natural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung 25451, Republic of Korea. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Chlorella vulgaris, Colitis, Microbiota. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Science and Technology, National Research Foundation of Korea.
Abstract (Originalsprache)
Chlorella vulgaris (C. vulgaris) is unicellular green algae consumed worldwide as a functional food. The immune stimulatory function of C. vulgaris is known; however, no study has elucidated its immune regulatory potential and associated microbiome modulation. In the current study, we aimed to validate the immune regulatory role of C. vulgaris mediated through two mechanisms. Initially, we assessed its ability to promote the expansion of the regulatory T cell (Treg) population. Subsequently, we investigated its impact on gut microbiota composition and associated metabolites. The supplementation of C. vulgaris altered the gut microbiota composition, accompanied by increased short-chain fatty acid (SCFAs) production in mice at homeostasis. We later used C. vulgaris in the treatment of a DSS-induced colitis model. C. vulgaris intervention alleviated the pathological symptom of colitis in mice, with a corresponding increase in Treg levels. As C. vulgaris is a safe and widely used food supplement, it can be a feasible strategy to instigate cross-talk between the host immune system and the intestinal flora for the effective management of inflammatory bowel disease (IBD).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung 25451, Republic of Korea.
- Department of Marine Food Science and Technology, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea.
- Department of Preventive Medicine, School of Medicine, Kangwon National University, Chuncheon 24341, Republic of Korea.
- Department of Microbiology and Immunology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Division of Bio-Medical Science and Technology, Korea Institute of Science and Technology (KIST), University of Science and Technology, Seoul 02792, Republic of Korea.
- Department of Convergence Medicine, Wonju College of Medicine, Yonsei University, Wonju 26493, Republic of Korea.
ORCID-Profile: Priyanka Velankanni, Seok-Ho Go, Jin-Soo Park, Cheol-Ho Pan, Kwang Hyun Cha, Choong-Gu Lee
Förderung
- Korea Institute of Science and Technology
- National Research Foundation of Korea
Zitieren
APA
Velankanni, P., Go, S. H., Jin, J. B., Park, J. S., Park, S., Lee, S. B., Kwon, H. K., Pan, C. H., Cha, K. H., & Lee, C. G. (2023). Chlorella vulgaris Modulates Gut Microbiota and Induces Regulatory T Cells to Alleviate Colitis in Mice. Nutrients, 15(15), 3293. https://doi.org/10.3390/nu15153293
Vancouver
Velankanni P, Go SH, Jin JB, Park JS, Park S, Lee SB, et al. Chlorella vulgaris Modulates Gut Microbiota and Induces Regulatory T Cells to Alleviate Colitis in Mice. Nutrients. 2023;15(15):3293. doi:10.3390/nu15153293
BibTeX
@article{Velankanni2023,
author = {Velankanni, Priyanka and Go, Seok-Ho and Jin, Jong Beom and Park, Jin-Soo and Park, Sunhee and Lee, Su-Bin and Kwon, Ho-Keun and Pan, Cheol-Ho and Cha, Kwang Hyun and Lee, Choong-Gu},
title = {Chlorella vulgaris Modulates Gut Microbiota and Induces Regulatory T Cells to Alleviate Colitis in Mice},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {15},
pages = {3293},
doi = {10.3390/nu15153293}
}
EUVIMED